出版國(guó)家:United States
出版周期:月刊
影響因子:1.718
研究領(lǐng)域:異構(gòu)、分子構(gòu)象
5年影響因子:2.062
國(guó)外數(shù)據(jù)庫(kù)收錄:IM,1.718" />
醫(yī)學(xué)全在線(xiàn)
醫(yī)學(xué)全在線(xiàn)首頁(yè)-醫(yī)師-藥師-護(hù)士-衛(wèi)生資格-高級(jí)職稱(chēng)-考試題庫(kù)-網(wǎng)校-考研-圖譜-下載-招聘  
分類(lèi)
國(guó)家級(jí)省級(jí)浙江省各省雜志
科技核心北大核心CSCDCSCD擴(kuò)展
工具
期刊知識(shí)寫(xiě)作指導(dǎo) 論文投稿推薦期刊
期刊驗(yàn)證論文檢測(cè) 錄用通知往期目錄
SCI
SCI指導(dǎo)影響因子
期刊點(diǎn)評(píng)基金動(dòng)態(tài)
其它
經(jīng)濟(jì)教育計(jì)算機(jī)
建筑體育農(nóng)業(yè)
北京|天津|河北|山西|湖北|江蘇|安徽|山東|上海|浙江|江西|福建|湖南|寧夏|內(nèi)蒙古|河南
四川|重慶|貴州|云南|遼寧|吉林|廣東|廣西|海南|陜西|甘肅|新疆|青海|衛(wèi)生部直屬|黑龍江|兵團(tuán)
您現(xiàn)在的位置: 醫(yī)學(xué)全在線(xiàn) > 醫(yī)學(xué)論文 > SCI期刊 > 正文:Chirality if:1.718
    

Chirality


Chirality
影響因子: 1.718
I S S N: 0899-0042
出 版 社: Wiley-Liss
出 版 地: New York Ny
出版國(guó)家: United States
刊  期: 月刊
創(chuàng)刊時(shí)間: 1989
語(yǔ)  種: 英文
審稿周期: 約1.0個(gè)月
中科院分區(qū): 3
投稿命中率: 容易
國(guó)外數(shù)據(jù)庫(kù)收錄: IM
中國(guó)收錄文章數(shù): 109
5年影響因子: 2.062
研究領(lǐng)域: 異構(gòu)、分子構(gòu)象
官方鏈接: http://onlinelibrary.wiley.com/journal/10.1002/(IS...
投稿須知: http://onlinelibrary.wiley.com/journal/10.1002/(IS...

期刊介紹:

The main aim of the journal is to publish scientific work on the role of molecular asymmetry in both biologically active and non-biologically active molecules in respect to their pharmacological biological and chemical properties. Drugs pesticides and other xenobiotics will be a major interest. Papers on the chemistry (physiochemical preparative synthetic and analytical) pharmacology clinical pharmacology toxicology and other biological aspects of chiral molecules will be published. Among the topics to be covered are stereospecific synthesis stereoselective analysis preparative separation of chiral molecules the influence of chirality on pharmacokinetics (absorption distribution protein binding biotransformation etc.) the influence of chirality on pharmacodynamics (drug-receptor interactions pharmacological and toxicological activity) and the influence of chirality on clinical pharmacology (therapeutic index and response bioavailability adverse drug reactions drug-drug interactions). Papers will also be published on regulatory and legal aspects in the development testing and marketing of chiral compounds. In addition to original research papers the journal will publish brief reviews short communications and conference reports. Book reviews will also appear
...
關(guān)于我們 - 聯(lián)系我們 -版權(quán)申明 -誠(chéng)聘英才 - 網(wǎng)站地圖 - 網(wǎng)絡(luò)課程 - 幫助
醫(yī)學(xué)全在線(xiàn) 版權(quán)所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP備12017320號(hào)
百度大聯(lián)盟認(rèn)證綠色會(huì)員實(shí)名網(wǎng)站 360認(rèn)證可信網(wǎng)站 中網(wǎng)驗(yàn)證